american diabetes association history of pancreatitis glp-1 receptor agonist The Emerging Role Glucagon-Like Peptide-1 Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis Beyond glycemia: Comparing tirzepatide to

These drugs are typically prescribed to adults and now teens, who are obese (BMI above 30)

Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study

[DOI] [PMC free article] [PubMed] [Google Scholar] 212.Phuwamongkolwiwat P., et al

Notably, discontinuation is associated with weight regain and partial or complete reversal of improvements in cardiometabolic risk factors, including inflammatory markers, blood pressure, lipid profile, and blood glucose levels

The maximum recommended dose is 70 mg per day

But true receptor downregulation through lysosomal degradation requires the cell to synthesize entirely new receptors, a process that takes considerably longer